The FDA supports a cannabis-derived drug, but it’s still too hard
20.04.2018 · At the same time, the FDA needs to more closely regulate this side industry of CBD products, because even though the real version of CBD could help heal, the $24 cannabis-oil mascara will hardly
GW Pharma : Epidiolex (CBD) validé par la FDA ce mardi
GW Pharma : Epidiolex (CBD) validé par la FDA ce mardi 16 Avril 2018.Le traitement de l'épilepsie à base de cannabis (CBD) de GW Pharmaceuticals, Epidiolex®, a reçu un avis favorable de la FDA mardi 17 Avril 2018, bien avant une réunion du comité consultatif prévue plus tard cette semaine
Epidiolex, the First FDA-Approved Cannabidiol Medication, Nears
What is Epidiolex for? Epidiolex is made by GW Pharmaceuticals and is approved by the FDA to treat seizures associated with Lennox-Gastaut syndrome or Dravet syndrome in patients 2 years of age and older.